BGMS Q3 2024 Earnings Narrowing Loss Beats Estimates by Wide Margin COFS Q1 2026 Earnings Earnings Beat Estimates as EPS Surpasses Consensus Kura Oncology Q1 2026 Earnings Wider Loss as Clinical Progress Continues VIOT Q4 2022 Earnings Loss Deepens as Revenue Data Remains Undisclosed FKWL Q1 2026 Earnings Significant EPS Miss and Stock Decline INTS Q1 2026 Earnings EPS Beat Despite PreRevenue Status Shares Edge Higher